Published in Lab Invest on June 01, 1994
Coronary vascular injury after transient coronary artery occlusion. Lab Invest (1993) 1.48
Apoptosis is the main mechanism of cardiomyocyte death in the hyperacute rejection of heart xeno- and allografts. Transplantation (1997) 1.71
Induction of apoptosis by laser: a new therapeutic modality. Lasers Surg Med (1998) 1.70
Pathogenesis of heart fibrosis in systemic sclerosis. Int J Cardiol (2001) 1.53
Pseudovascular tubes obscure transmyocardial revascularization. Ann Thorac Surg (1997) 1.41
Hyperplastic capillaries and their possible involvement in the pathogenesis of fibrosis. Histopathology (1986) 1.16
Further diseases manifesting a uniform vascular response to different aetiological factors. Histopathology (1985) 1.08
Eosinophilic droplet formation, a morphologic manifestation of cardiomyocyte apoptosis, is present in the humoral (microvascular) rejection of human cardiac allografts. Transplantation (1998) 1.08
Cardiac hyperacute rejection: a new look at an old problem. J Heart Lung Transplant (2000) 1.08
Quick disposal of dead cardiomyocytes: an ultimate proof of apoptosis. J Heart Lung Transplant (2001) 0.95
C-reactive protein and complement in myocardial infarction and postinfarction heart failure. Eur Heart J (1997) 0.94
Angiogenesis induced by transmyocardial laser revascularization. Ann Thorac Surg (1998) 0.91
CD68 is not a macrophage-specific antigen. Ann Rheum Dis (2005) 0.90
Antiangiogenesis in hematologic diseases. Ann Hematol (2001) 0.90
Thanatosomes and cardiomyocyte apoptotic bodies. Hum Pathol (2001) 0.87
Transplantation of human malignant mesothelioma into nude mice. Cancer Res (1980) 0.86
Further evidence of cardiomyocyte apoptosis in hyperacute rejection. J Heart Lung Transplant (2002) 0.83
Antibody HAM56 is not macrophage-specific in vein autografts. Am J Cardiol (1991) 0.83
Transformation of capillaries into interstitial tissue: further evidence in favour of the angiogenic hypothesis of repair and fibrosis. Br J Plast Surg (1989) 0.82
Vascular endothelium-derived cells containing smooth muscle actin are present in restenosis. Lab Invest (1995) 0.81
Further evidence of cardiomyocyte apoptosis in humoral (microvascular) rejection of human cardiac allografts. J Heart Lung Transplant (2004) 0.80
Why does topical silicone gel improve hypertrophic scars? A hypothesis. Surgery (1990) 0.80
Terminal complement-complex in myocardial reperfusion injury. Cardiovasc Res (1997) 0.79
C-reactive protein in postinfarction heart rupture. Am Heart J (1998) 0.79
Hyalin degeneration in the cardiomyopathy of overload. J Mol Cell Cardiol (1995) 0.77
Factor VIII-related antigen in the cardiac myxoma: its relevance to tumor histogenesis. Arch Pathol Lab Med (1989) 0.77
Myocardial defects in hyperacute cardiac rejection: evidence of cardiomyocyte apoptosis. Transplantation (2000) 0.77
Preventive treatment of postinfarction heart rupture. Cardiovasc Drugs Ther (1995) 0.77
Prednisolone enhancement of primary endocrine anticancer treatment: a possible anti-angiogenic effect. Br J Cancer (1989) 0.76
Endothelial hyperplasia: an important indicator of actual angiogenesis. Br J Cancer (2002) 0.76
Undifferentiated vascular endothelial cells in coronary allograft atherosclerosis. Int J Cardiol (1990) 0.76
Alpha-smooth muscle actin is not a specific and, consequently, a reliable marker for smooth muscle cells. Hum Pathol (1993) 0.76
Are dysplastic intramyocardial artery-like structures in hypertrophic cardiomyopathy really coronary vessels? Eur Heart J (1994) 0.75
Vascular endothelial cell is a stem cell for neointimal formation after injury. J Thorac Cardiovasc Surg (2001) 0.75
Toxic oil syndrome. Am Heart J (1991) 0.75
Angiogenic histogenesis of non-hematopoietic mesenchymal hyperplasias and tumors. J Cutan Pathol (1990) 0.75
Myocardial pseudovascular tubes are present in the delayed rejection of pig-to-baboon orthotopic cardiac xenografts. J Thorac Cardiovasc Surg (1999) 0.75
Myocardial pseudovascular tubes are present in the delayed rejection of heart xenografts. Transplantation (1997) 0.75
Endothelial cells and not smooth muscle cells are affected during a photodynamic therapy of atherosclerotic plaques. J Am Coll Cardiol (1991) 0.75
The sympathetic denervation induced by transmyocardial laser revascularization protects the affected tissue. J Thorac Cardiovasc Surg (1999) 0.75
Juvenile xanthogranuloma. Am J Surg Pathol (1991) 0.75
Are all bizarre intramyocardial artery-like structures in human cardiac allografts really coronary vessels? Histopathology (1997) 0.75
Does intensive medical therapy influence the outcome in unstable angina? Clin Cardiol (1991) 0.75
Combined cytotoxicity effect of hyperthermia and anthracycline antibiotics on human tumor cells. J Natl Cancer Inst (1985) 0.75
Lipoma and the liposarcoma: genuine angiogenic lesions. J Laryngol Otol (1990) 0.75
Angiogenesis in psoriasis. Lab Invest (1990) 0.75
Angiotensin converting enzyme in rheumatoid arthritis. Ann Rheum Dis (1993) 0.75
Are there hyperplastic capillaries in Sneddon's syndrome? Hum Pathol (1992) 0.75
Apoptosis in transmyocardial and percutaneous myocardial revascularization. Mayo Clin Proc (1999) 0.75
Stenting of coronary arteries. J Am Coll Cardiol (1991) 0.75
Lymphatic angiogenesis induced by transmyocardial laser revascularization. Ann Thorac Surg (1999) 0.75
Are undifferentiated vascular endothelial cells present in gastric artery dissection? Surgery (1991) 0.75
Anitschkow cells in experimental autoimmune myocarditis. Circulation (1992) 0.75
Corticosteroids for prevention of restenosis after angioplasty. Cathet Cardiovasc Diagn (1990) 0.75
Emerging new concepts of myocardial laser revascularization. J Thorac Cardiovasc Surg (1999) 0.75
Does growth hormone reduce fibrosis? Cardiovasc Res (1999) 0.75
Does endocardial laser revascularization induce "pseudovascular muscle tubes"? Ann Thorac Surg (1994) 0.75
Origin of non-haematogenous synovial lining cells in inflammatory hyperplasia. J R Soc Med (1988) 0.75
Are myocardial 'pseudovascular muscle tubes' present in acromegalic hearts? Clin Endocrinol (Oxf) (1999) 0.75
Osler's disease is not a telangiectasia but a tumour. Gut (1990) 0.75
Laser-mediated transmural myocardial channels induce a hyalin degeneration of neighboring myocardium. J Am Coll Cardiol (1994) 0.75
Are restenosis cells containing nonmuscle myosin really vascular smooth muscle cells? Circulation (1992) 0.75
Sweat gland-like cutaneous hyperplastic capillaries: a neglected phenomenon. Acta Derm Venereol (1993) 0.75
Aschoff node histogenesis. Int J Cardiol (1992) 0.75
Why complement attacks cardiomyocytes in hyperacute heart rejection. J Thorac Cardiovasc Surg (2001) 0.75
Histogenesis of vascular tumours. J Hand Surg Br (1996) 0.75
Efficacy of corticosteroids in suppression of intimal hyperplasia: a possible antiangiogenic effect. J Vasc Surg (1990) 0.75
Do neutrophils contribute to the clearance of injured cardiomyocytes in reperfusion injury? J Pathol (1997) 0.75
Progression of coronary stenosis. Am Heart J (1991) 0.75
Origin of the smooth muscle cells in intimal hyperplasia: do we come to the end of the tunnel? J Heart Lung Transplant (1993) 0.75
Hyaline degeneration in heart infarction. Cardiovasc Res (1995) 0.75
Nasopharyngeal angiofibroma revisited. Laryngoscope (1990) 0.75
Why do channels remain patent after transmyocardial laser revascularization? Ann Thorac Surg (1998) 0.75
Pathogenesis of transverse midventricular disruption. Int J Cardiol (2001) 0.75
Silicone gel sheeting for the management of hypertrophic and keloid scars: the mechanism of its action. Dermatol Surg (1997) 0.75
The presence of angiogenesis in rejection. Transplantation (1990) 0.75
Eosinophilic droplets similar to red cells are present in the hyperacute rejection of heart xenografts. J Intern Med (1997) 0.75
Why growth hormone therapy is efficient in heart failure? Eur Heart J (1999) 0.75
Apoptosis contributes to cyclophosphamide-induced cardiomyopathy. Bone Marrow Transplant (2002) 0.75
Restenosis comes of age. Mayo Clin Proc (1993) 0.75
In situ DNA nick-end labeling positive reaction around laser channels. Thorac Cardiovasc Surg (2001) 0.75
Histogenesis of the intimal thickening in atherosclerosis and of hyperplastic processes in connective tissue. Hum Pathol (1990) 0.75
Smooth muscle cells and macrophages in rabbit cardiac allograft atherosclerosis. J Heart Transplant (1991) 0.75
Hyalin degeneration. Present in heart infarction & implicated in pathogenesis of heart rupture. Chest (1994) 0.75
Binding of morphine by serum globulins from morphine-treated rabbits. II. Antibody nature of the binding globulins. Int Arch Allergy Appl Immunol (1976) 0.75
Undifferentiated vascular endothelial and inflammatory cells in vascular rejection. J Heart Lung Transplant (1992) 0.75
Angiogenesis and basic fibroblast growth factor. Br J Plast Surg (1992) 0.75
Chemotherapeutic sensitivity of acute lymphoblastic leukemia cells in culture: correlation with clinical efficacy on donor patients. Cancer Drug Deliv (1984) 0.75
Controversial histogenesis of the malignant fibrous histiocytoma. Am J Clin Pathol (1987) 0.75
Histogenesis of vascular spiders. Hepatology (1990) 0.75
Occurrence of factor VIII-related antigen positive cells in perivascular infiltrates of venous stasis dermatitis. Br J Dermatol (1985) 0.75
Hyperplastic capillaries and renal tubules in chronic transplant rejection. Histopathology (1988) 0.75
Antiangiogenesis: a suitable preventive treatment of restenosis. Cathet Cardiovasc Diagn (1993) 0.75
Antiangiogenesis--a possible treatment for veno-occlusive hepatic disease? Bone Marrow Transplant (1990) 0.75
Diabetic retinopathy: a self-sustaining process. Lancet (1988) 0.75
Cholesterol lowering trials and the theory of atherosclerosis. N Z Med J (1993) 0.75
Bone marrow fibroblast colony-forming cells are osteogenic stem cells. Cell Tissue Kinet (1988) 0.75
Outgrowths from pelleted vascular endothelial and mesenchymal cells. Cell Biol Int Rep (1988) 0.75
Undifferentiated vascular endothelial cells present in transplantation atherosclerosis display smooth muscle actin-positive cytoplasmic myofilaments. J Heart Lung Transplant (1993) 0.75
Hyperplastic renal capillaries in obstructive nephropathy. Lab Invest (1988) 0.75
Fibrosis in hypertrophic cardiomyopathy: its possible pathogenesis. J Am Coll Cardiol (1990) 0.75